Experts across UCSF weigh in on what some of 2014's top trends are in research and patient care.
December 18, 2013
December 17, 2013
Some of the world's top researchers converged at UCSF as part of a two-day celebration of the 2014 Breakthrough Prize in Life Sciences, nicknamed the "Oscars of Science."
November 15, 2013
Precision Medicine Pillar No. 2: Basic Discovery. The long path to developing potent new treatments often starts with an observation in the lab that then leads to a question about a fundamental life process.
October 16, 2013
A UCSF-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.
December 06, 2012
Precision medicine and cancer genetics were among the topics discussed during 11 breakout sessions guided by 30 UCSF faculty members at the Nov. 7 showcase for the UCSF Helen Diller Family Comprehensive Cancer Center.
December 06, 2012
The rate of cancer survival is expected to keep climbing in coming years largely thanks to research discoveries that are translating into new cancer drugs, which currently account for roughly 30 percent of the pharmaceutical dollar, the chief scientific officer at Bristol-Myers Squib recently said at a showcase event for the UCSF Helen Diller Family Comprehensive Cancer Center.
December 04, 2012
The National Center for Advancing Translational Sciences at the National Institutes of Health has awarded nearly a half-million dollars to UCSF's Clinical and Translational Science Institute for a collaborative research project on oral cancer.
November 27, 2012
A team of researchers from UCSF and the University of Pennsylvania has uncovered how a normal biological mechanism called the “unfolded protein response,” goes awry in human lymphoma – work that may lead to the development of specific drugs to fight different forms of cancer.
September 28, 2012
September is National Childhood Cancer Awareness month, encouraging awareness and affirmation to the commitment of fighting pediatric cancer.
September 13, 2012
Biomedical researchers at UCSF have won five of 51 prestigious National Institutes of Health Director’s New Innovator awards for high-risk, high-reward research, each receiving up to $1.5 million over five years.